CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹4,155 Cr | ₹2,835 Cr | ₹2,559 Cr | ₹2,401 Cr | ₹1,547 Cr |
What is the latest Profit After Tax of CIPLA ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹4,155 Cr |
| Mar2024 | ₹2,835 Cr |
| Mar2023 | ₹2,559 Cr |
| Mar2022 | ₹2,401 Cr |
| Mar2021 | ₹1,547 Cr |
How is Profit After Tax of CIPLA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,155 Cr | 46.55 | |
| Mar2024 | ₹2,835 Cr | 10.78 | |
| Mar2023 | ₹2,559 Cr | 6.59 | |
| Mar2022 | ₹2,401 Cr | 55.23 | |
| Mar2021 | ₹1,547 Cr | - | |
Compare Profit After Tax of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹99,763.3 Cr | 0.4% | -2.6% | -17.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -1.4% | -6.2% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,939.0 Cr | -0.1% | 2.3% | 9.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,109.0 Cr | -1.8% | -4.9% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,578.0 Cr | -0.4% | -6% | 5.3% | Stock Analytics | |
| MANKIND PHARMA | ₹92,275.4 Cr | 6.2% | 6.3% | -13% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.4% |
-2.6% |
-17.6% |
| SENSEX | 0.5% |
3.2% |
2.3% |
You may also like the below Video Courses